Ovarian Immature Teratoma with Gliomatosis Peritonei and Nodal Gliomatosis Metastasis: A Case Report

Jiaxin Zhang, Hui Ji, Meiyu Sun, Jiahui Wang, P. Liu, Lu Feng, PengXin Zhang, Jingchun GaoInternational Journal of Women s Health 2025 · DOI

Abstract

Gliomatosis peritonei (GP) is a rare condition characterized by the presence of mature glial tissue within the peritoneum. It is infrequently observed in young women or pediatric patients with ovarian teratomas. This report describes a case of ovarian immature teratoma (OIT) associated with both GP and nodal gliomatosis (NG)—the metastasis of mature neuroglial components to the lymph nodes.

Introduction

Ovarian immature teratomas (OIT) are malignant germ cell tumors containing tissues derived from all three germ layers, notably including immature neuroepithelium. A rare but significant association exists between OIT and Gliomatosis Peritonei (GP), where thousands of benign, mature glial nodules scatter across the peritoneal surface. Even rarer is Nodal Gliomatosis (NG), involving the spread of this mature tissue to regional lymph nodes. With only approximately 100 cases of GP reported worldwide, standardized management protocols remain elusive due to the condition's extreme rarity.

Clinical Presentation and Diagnostics

A 23-year-old patient presented with a significant 20 cm pelvic mass. Clinical evaluation included physical examination, serum tumor marker analysis (CA125, CA19-9, HE4), and advanced imaging. Enhanced CT scans were pivotal in identifying the extent of the disease, revealing a large, heterogeneous mass occupying the pelvic and abdominal cavities, accompanied by numerous peritoneal nodules.

Enhanced CT scans (a-d) showing the large pelvic mass and associated peritoneal nodules (red arrows).

Surgical and Pathological Findings

The patient underwent a transabdominal right adnexectomy combined with pelvic and para-aortic lymph node dissection. Histopathological analysis of the primary tumor confirmed a Grade G1 (low-grade) immature teratoma.

To differentiate the peritoneal nodules and lymph node involvement from malignant spread, the authors utilized Immunohistochemistry (IHC). The tissues tested positive for Glial Fibrillary Acidic Protein (GFAP), confirming they consisted of mature, benign glial tissue. This finding established the diagnosis of concurrent GP and NG, highlighting that even mature tissue can metastasize via lymphatic vessels.

Histopathological images at 10X and 20X magnification showing mature neuroglial components (red arrows) consistent with gliomatosis.

Discussion: The "Benign" Metastasis Paradox

The most striking feature of GP and NG is the "Benign Metastasis Paradox": while the primary OIT is malignant, the secondary implants are histologically mature and benign. This can lead to a clinical "reversal" where the patient's condition shifts from malignant to benign as the tissue matures.

Pathogenesis and Diagnostic Challenges

Two primary theories explain the development of these glial nodules:

  1. Spillage: Malignant cells leak from a ruptured tumor and subsequently mature within the abdominal cavity.
  2. Metaplasia: Multipotential stem cells in the peritoneum differentiate into glial cells in response to chemical signals from the tumor.

Clinically, GP often mimics tuberculous peritonitis or peritoneal carcinomatosis during surgery. Intraoperative frozen section pathology is essential to prevent aggressive over-treatment.

Conclusion and Prognosis

While GP generally suggests a more favorable prognosis, the combination with OIT requires intensive long-term follow-up. In this case, a 4x2 cm hepatic recurrence (also Grade G1 OIT) was detected six months post-surgery, requiring further laparoscopic resection.

Currently, there is no "gold standard" for whether these patients require aggressive chemotherapy if the implants are purely mature. Future molecular genetic studies are needed to definitively determine the origin of these nodules, which will help refine clinical surveillance and treatment strategies for this rare triad.

Summary updated

Abstract

Gliomatosis peritonei (GP) is a rare condition of mature glial tissue within the peritoneum. GP has been reported in approximately 100 cases worldwide, and it rarely occurs in young women or in patients with ovarian mature or immature teratomas during childhood. In patients with ovarian immature teratoma (OIT) combined with gliomatosis peritonei, the tumor is typically large and is often detected intraoperatively. Its neuroglial component may not only spread within the peritoneum but also metastasize via the lymphatic vessels. Pathologically confirmed lymph nodes containing mature neuroglial components and positive for glial fibrillary acidic protein (GFAP) are consistent with nodal gliomatosis (NG). In this report, we present a case of gliomatosis associated with OIT combined with GP, which involves lymph nodes.
BibTeX
@article{zhang2025ovarian,
  author = {Jiaxin Zhang and Hui Ji and Meiyu Sun and Jiahui Wang and P. Liu and Lu Feng and PengXin Zhang and Jingchun Gao},
  title = {{Ovarian Immature Teratoma with Gliomatosis Peritonei and Nodal Gliomatosis Metastasis: A Case Report}},
  journal = {International Journal of Women s Health},
  year = {2025},
  doi = {10.2147/ijwh.s553268},
}
Figure